Vertebral Fractures and Role of Low Bone Mineral Density in Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 6, 2007, Pages 721-728

  Siffledeen, Jesse S ^a   Siminoski, Kerry ^a   Jen, Ho ^a   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; PARATHYROID HORMONE;

ADULT; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MORPHOMETRICS; PREDICTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

ADULT; AGE FACTORS; BONE DENSITY; C-REACTIVE PROTEIN; CROHN DISEASE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; SPINAL FRACTURES;

EID: 34249722226     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.02.024     Document Type: Article

References (62)

1. Habtezion A., Silverberg M.S., Parkes R., et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 8 (2002) 87-92
2. Dinca M., Fries W., Luisetto G., et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 94 (1999) 1292-1297
3. Compston J.E., Judd D., Crawley E.O., et al. Osteoporosis in patients with inflammatory bowel disease. Gut 28 (1987) 410-415
4. Ardizzone S., Bollani S., Bettica P., et al. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 247 (2000) 63-70
5. Dressner-Pollak R., Karmeli F., Eliakim R., et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 93 (1998) 1483-1490
6. Jahnsen J., Falch J.A., Aadland E., et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 40 (1997) 313-319
7. Robinson R.J., Al Azzawi F., Iqbal S.J., et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 43 (1998) 2500-2506
8. Bjarnason I., Macpherson A., Mackintosh C., et al. Reduced bone density in patients with inflammatory bowel disease. Gut 40 (1997) 228-233
9. Schoon E.J., Van Nunen A.B., Wouters R.S.M.E., et al. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol 35 (2000) 43-47
10. Schulte C., Dignass A., Mann K., et al. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 4 (1998) 268-275
11. Siffledeen J., Fedorak R.N., Siminoski K., et al. Bones and Crohn's: analysis of risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 10 (2004) 220-228
12. Stockbrugger R.W., Schoon E.J., Bollani S., et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 16 (2002) 1519-1527
13. Klaus J., Armbrecht G., Steinkamp M., et al. High pervalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 51 (2002) 654-658
14. Loftus E.V.J., Crowson C.S., Sandborn W.J., et al. Long term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 123 (2002) 468-475
15. Van Staa T.-J., Cooper C., Brusse L.S., et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 125 (2003) 1591-1597
16. Bernstein C.N., Blanchard J.F., Leslie W., et al. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med 133 (2000) 795-799
17. Vestergaard P., and Mosekilde L. Fracture risk in patients with Celiac disease, Crohn's disease and ulcerative colitis: a nationwide follow-up study of 16, 416 patients in Denmark. Am J Epidemiol 156 (2002) 1-10
18. Vestergaard P., Krogh K., Rejnmark L., et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 46 (2000) 176-181
19. Cooper C., O'Neill T., and Silman A. The epidemiology of vertebral fractures. Bone 14 (1993) S89-S97
20. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Bone 312 (1996) 1254-1259
21. Black D.M., Steinbuch M., Palermo L., et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12 (2001) 519-528
22. Kanis J., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
23. Delmas P.D., Genant H.K., Crans G.G., et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33 (2003) 522-532
24. Brown J.P., and Josse R.G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 (2002) S1-S34
25. Papaioannou A., Joseph L., Brown J.P., et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 16 (2005) 568-578
26. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Technical Report Series 843 (1994), WHO, Geneva
27. Kanis J.A., Johnell O., De Laet C., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 (2004) 375-382
28. Ross P.D., Davis J.W., Epstein R.S., et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114 (1991) 919-923
29. Nevitt M.C., Ettinger B., Black D.M., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128 (1998) 793-800
30. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial: Multiple Outcomes of Raloxifene Evaluation (MORE) investigators. JAMA 282 (1999) 637-645
31. Grigoryan M., Guermazi A., Roemer F.W., et al. Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12 Suppl 2 (2003) S104-S112
32. van Staa T.P., Dennison E.M., Leufkens H.G., et al. Epidemiology of fractures in England and Wales. Bone 29 (2001) 517-522
33. Majumdar S.R., Kim N., Colman I., et al. Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165 (2005) 905-909
34. Looker A.C., Orwoll E.S., Johnston C.C., et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 12 (1997) 1761-1768
35. Melton III L.J., Kan S.H., Frye M.A., et al. Epidemiology of vertebral fractures in women. Am J Epidemiol 129 (1989) 1000-1011
36. Ferguson S.J., and Steffen T. Biomechanics of the aging spine. Eur Spine J 12 (2003) S97-S103
37. Kleerekoper M., and Nelson D.A. Vertebral fracture or vertebral deformity. Calcif Tissue Int 50 (1992) 5-6
38. Genant H.K., Wu C.Y., Van Kuijk C., et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8 (1993) 1137-1148
39. Genant H.K., Jergas M., Palermo L., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11 (1996) 984-996
40. Wu C.Y., Li J., Jergas M., et al. Semiquantitative and quantitative assessment of incident fractures: comparison of methods. J Bone Miner Res 9 (1994) S157
41. Crans G.G., Genant H.K., and Krege J.H. Prognostic utility of a semiquantitative spinal deformity index. Bone 37 (2005) 175-179
42. Jackson S.A., Tenenhouse A., and Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11 (2000) 680-687
43. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103 (1997) 3S-8S
44. TEPOSE Group. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17 (2002) 716-724
45. O'Neill T.W., Felsenberg D., Varlow J., et al. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11 (1996) 1010-1018
46. Cooper C., Atkinson E.J., O'Fallon W.M., et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7 (1992) 221-227
47. Wada T., Nakashima T., Hiroshi N., et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12 (2006) 17-25
48. Atkins G.J., Kostakis P., Pan B., et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18 (2003) 1088-1098
49. Bernstein C.N., and Leslie W.D. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 15 (2003) 857-864
50. Bernstein C.N., Sargent M., and Leslie W.D. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflamm Bowel Dis 11 (2005) 325-330
51. Kitaura H., Sands M.S., Aya K., et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173 (2004) 4838-4846
52. Komine M., Kukita A., Kukita T., et al. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 28 (2001) 474-483
53. Liu X.H., Kirschenbaum A., Yao S., et al. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 146 (2005) 1991-1998
54. Parfitt A.M. Trabecular bone architecture in the pathogenesis and prevention of fracture. Am J Med 82 (1987) 68-72
55. Miyakoshi N. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis. Curr Pharm Des 10 (2004) 2615-2627
56. Compston J.E., Ayers A.B., Horton L.W., et al. Osteomalacia after small-intestinal resection. Lancet 1 (1978) 9-12
57. Vogelsang H., Ferenci P., Woloszczuk W., et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 34 (1989) 1094-1099
58. Hessov I., Mosekilde L., Melsen F., et al. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease. Scand J Gastroenterol 19 (1984) 691-696
59. Croucher P.I., Vedi S., Motley R.J., et al. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int 3 (1993) 236-241
60. Huang J.C., Sakata T., Pfleger L.L., et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19 (2004) 235-244
61. Bischoff S., Herrmann A., Goke M., et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 92 (1997) 1157-1163
62. Motley R.J., Crawley E.O., Evans C., et al. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 29 (1988) 1332-1336